Detalhe da pesquisa
1.
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Qual Life Res
; 32(8): 2281-2292, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935467
2.
Reprint of: Examining Medicare Part D Medication Therapy Management program in the context of mental health.
J Am Pharm Assoc (2003)
; 60(5S): S54-S63, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32977930
3.
Examining Medicare Part D Medication Therapy Management program in the context of mental health.
J Am Pharm Assoc (2003)
; 60(4): 571-579.e1, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953120
4.
Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
J Geriatr Oncol
; 15(2): 101681, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104480
5.
Pharmacogenomics education, research and clinical implementation in the state of Minnesota.
Pharmacogenomics
; 22(11): 681-691, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137665